Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog > Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl
	Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl
  • 	Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl
  • 	Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl
  • 	Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl
  • 	Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl
  • 	Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl

Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl Min. Order: 10mg
Purity: 99%+ HPLC Supply Ability: 1000
Release date: 2025/07/31

Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl

Article illustration


Product Information

  • Product Code: I042016

  • English Name: Indomethacin Sorbitol Ester 1:Primoryl Hydroxyl

  • English Alias: (2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate

  • CAS No.: Not provided

  • Molecular Formula: C₂₅H₂₈ClNO₉

  • Molecular Weight: 521.94

Advantages

  • As an ester derivative of indomethacin and sorbitol, it combines the anti-inflammatory activity of indomethacin with the hydrophilicity of sorbitol, potentially improving the water solubility and bioavailability of the parent drug.

  • The structure contains polyhydroxyl functional groups, which can be used as a novel prodrug or excipient for formulation development, providing more possibilities for drug delivery systems.

Applications

  • Pharmaceutical Formulation R&D: Used to develop sustained-release or targeted formulations of indomethacin, regulating drug release rate through esterification modification to reduce gastrointestinal irritation.

  • Prodrug Research: As a prodrug candidate, study its hydrolytic metabolic pathway and activity conversion in vivo to optimize pharmacokinetic properties.

  • Excipient Compatibility Study: Evaluate its compatibility with other drug components as a functional excipient for (compound formulation) development.

Background Description

Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) commonly used in treating inflammatory diseases such as arthritis, but it suffers from poor water solubility and significant gastrointestinal side effects. Esterification with sorbitol to form derivatives aims to improve its physicochemical properties (e.g., solubility, stability) while retaining or enhancing efficacy. The research background of such derivatives is closely related to the clinical pain points of NSAID drugs, i.e., improving therapeutic compliance and safety through molecular modification.

Research Status

  • Synthesis Process: Currently mainly prepared by esterification reaction, with research focusing on optimizing reaction conditions (such as catalyst, temperature) to improve yield and purity.

  • Efficacy Research: In vitro experiments show that some derivatives have anti-inflammatory activity comparable to indomethacin, but their in vivo metabolic mechanisms (such as ester bond hydrolysis rate) still need further verification.

  • Formulation Application: Preliminary studies indicate that such esters can achieve controlled release through solid dispersion or microsphere formulations, and related dosage forms are in the preclinical evaluation stage.


WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 


Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-04-28
$59.00/2mg
VIP6Y
TargetMol Chemicals Inc.
2025-09-11
$/
VIP5Y
RongNa Biotechnology Co.,Ltd
2025-04-29
INQUIRY